Regarding hematologic malignancies, the anti-apoptotic molecules Bcl-2 and Mcl-1 are commonly highly expressed, playing a pivotal role in their biological characteristics via the dysregulation of their expression or by being associated with the cell-of-origin of the hematologic neoplasm [42]. Here, BCL2 is linked to hematologic disorder.